Cyclodextrin-based nanosponges as promising carriers for active agents

S Allahyari, F Trotta, H Valizadeh… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: In recent years, new drug delivery systems have attempted to overcome the
undesirable pharmacokinetic problems of various drugs. Among them, cyclodextrin …

Preparation and characterization of cyclodextrin nanosponges for bortezomib delivery

S Allahyari, H Valizadeh, L Roshangar… - Expert Opinion on …, 2020 - Taylor & Francis
Background Bortezomib (BTZ) as an anticancer drug has been used through the injection
pathway. Research design and methods Two types of Cyclodextrin nanosponges (CDNSs) …

The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system

P Zakeri-Milani, BD Loveymi, M Jelvehgari… - Colloids and Surfaces B …, 2013 - Elsevier
AIM: In the present investigation, vancomycin (VCM) biodegradable nanoparticles were
developed for oral administration, with the aim of improving its intestinal permeability …

Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions

P Zakeri-Milani, H Valizadeh - Expert opinion on drug metabolism …, 2014 - Taylor & Francis
Introduction: There are many factors that can affect the absorption process of orally
administered drugs. Intestinal transporters play an important role in drug absorption. These …

[HTML][HTML] Anti-bacterial performance of azithromycin nanoparticles as colloidal drug delivery system against different gram-negative and gram-positive bacteria

M Azhdarzadeh, F Lotfipour… - Advanced …, 2012 - ncbi.nlm.nih.gov
Purpose: Azithromycin (AZI) is a new macrolide antibiotic with a better activity against
intracellular gram negative bacteria in comparison with Erythromycin. The purpose of this …

[HTML][HTML] Reduced ABCB1 expression and activity in the presence of acrylic copolymers

R Mohammadzadeh, B Baradaran… - Advanced …, 2014 - ncbi.nlm.nih.gov
Purpose: P-glycoprotein (P-gp; ABCB1), an integral membrane protein in the apical surface
of human intestinal epithelial cells, plays a crucial role in the intestinal transport and efflux …

[HTML][HTML] Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability

BD Loveymi, M Jelvehgari, P Zakeri-Milani… - Advanced …, 2012 - ncbi.nlm.nih.gov
Purpose: The purpose of this work was to preparation of vancomycin (VCM) biodegradable
nanoparticles to improve the intestinal permeability, using water-in-oil-in-water (W/O/W) …

A Novel Oral Drugs Delivery System for Borneol Based on HiCap®100 and Maltodextrin: Preparation, Characterization, and the Investigation as an Intestinal …

Y Chen, X Jin, Y Kuang, S Zhang, C Zhang, C Li… - AAPS …, 2023 - Springer
The objective of this study was to create a new method for delivering oral borneol (BN) drug
that would improve stability. This was accomplished through microencapsulation using …

Rat intestinal drug permeability: A status report and summary of repeated determinations

IR Dubbelboer, D Dahlgren, E Sjögren… - European Journal of …, 2019 - Elsevier
Intestinal permeability is a key biopharmaceutical variable in pharmaceutical research and
development, and regulatory assessment. In situ rat models are often used to predict the …

A study on enhanced intestinal permeability of clarithromycin nanoparticles

P Zakeri-Milani, Z Islambulchilar… - Brazilian Journal of …, 2014 - SciELO Brasil
The main objective of the present study was to determine the permeability of clarithromycin
(CLA)-PLGA nanoparticles using single-pass intestinal perfusion technique in rats …